MedDataX Logo

IMTAP : Impact of the Suicide Attempt on the Nearly Entourage in Term of Traumatic Stress and Medico-economic Impact

NCT ID: NCT01213797

Last Updated: 2011-10-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

372 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-03-31

Study Completion Date

2010-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

With 11.000 deaths and 150.000 attempts each year in France, the suicide represents an important public health problem. For each death by suicide, one can count 6 "direct" bereaved people and 20 people in more indirect connection with this mourning (Terra 2001). In term of impact, there is thus 300.000 people (annually) touched by the deaths by suicide and 3.750.000 people (annually) touched by the "suicide attempt" of a close relative. It seems indeed important to have Public Health data on this cascade repercussion of the suicide attempt.

A suicide attempt propagates a suffering cascade on the various circles of the family and close entourage, which can be measured in term of traumatic stress and medico-economic impact.

Objective = To measure the medico-economic impact on the entourage, in the 3 months following the suicide attempt and at 1 year.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Secondary objectives = To measure the impact of the suicide attempt in traumatic term of stress on the close relatives of committing suicide confronted with the suicidal scene To compare the evolution of consumption of care of the close relatives and of committing suicide To measure the evolution of the general health condition of the close relatives and of committing suicide

The study participants (committing suicide it and the relatives) will be recontacted by telephone, after 3 months and to 1 year.

Consumption of care (number of consultations, drugs consumption) of the population of the close relatives of committing suicide will be compared with the data of the Research Institute and Documentation in Economy of Health (IRDES) on the French population (sample of 20.000 people, representative of 95% of the French households).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Suicide, Attempted Relatives

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Suicide attempter and its entourage

Suicide attempter and its close relatives (who are living under the same roof)

Comparison of the population of the close relations of committing suicide with the data of the Research Institute and Documentation in Economy of Health (IRDES) on the French population (sample of 20.000 people, representative of 95% of the French households).

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men or women
* Older than 18 years
* Survivor with an suicide attempt going back to less than 15 days


* Men or women
* age more than 18 years
* Members of the entourage of committing suicide
* Living under the same roof as committing suicide it
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Lille

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Guillaume VAIVA

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Lille

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital, Angers

Angers, , France

Site Status

University Hospital, Brest

Brest, , France

Site Status

University Hospital, Caen

Caen, , France

Site Status

University Hospital, Clermont-Ferrand

Clermont-Ferrand, , France

Site Status

University Hospital, Lille

Lille, , France

Site Status

University Hospital, Limoges

Limoges, , France

Site Status

Le Vinatier Hospital

Lyon, , France

Site Status

University Hospital, Nancy

Nancy, , France

Site Status

University Hospital, Nice

Nice, , France

Site Status

Tenon Hospital, Paris

Paris, , France

Site Status

General Hospital, Quimper

Quimper, , France

Site Status

EPSM Lille Metropole

Tourcoing, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PHRC 2005/1917

Identifier Type: OTHER

Identifier Source: secondary_id

2006/0603

Identifier Type: OTHER

Identifier Source: secondary_id

DGS 2006/0116

Identifier Type: -

Identifier Source: org_study_id